Carl Walkey - 04 Jun 2021 Form 4 Insider Report for Neoleukin Therapeutics, Inc. (NGNE)

Role
Senior Vice President
Signature
/s/ Kris McGrew, as Attorney-in-Fact for Carl Walkey
Issuer symbol
NGNE
Transactions as of
04 Jun 2021
Net transactions value
-$6,000
Form type
4
Filing time
07 Jun 2021, 17:07:10 UTC
Previous filing
26 May 2021
Next filing
09 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NLTX Common Stock Sale $6,000 -600 -0.04% $10.00* 1,354,339 04 Jun 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.